SkinBioTherapeutics PLC

Croda: A Game-Changer in Beauty Innovation

By Elric Langton & Alex Langton | 30 January 2025

The finalisation of commercial terms between SkinBioTherapeutics and Croda marks a defining moment in the company’s transformation from cutting-edge biotech to a commercial powerhouse. The extended testing phase has validated the technology and unearthed “technical enhancements” additional benefits that amplify its market potential. This isn’t just progress—it’s a breakthrough. So, expect new commercial pathways beyond cosmetics. For now, these enhancements are a closely guarded secret.

A Masterfully Executed Launch Strategy

We don’t know what the enhancements are. Still, Dr Cico from Sederma will present at Cosmetin Lyon in February, discussing skin and brain interaction. We already know she will attend the in-cosmetics launch in April, discussing innovative cosmetic ingredients to reduce psychological stress. Could this be an area outside the cosmetic market?